Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed

E. Arevalo,Eduardo Castanon,Inés López,Josefa Salgado,Víctor Collado,Marta Santisteban,Maria E. Rodriguez-Ruiz,Patricia Martin,Leire Zubiri,Ana Patiño García,Christian Rolfo,Ignacio Gil Bazo

Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed

2014

E. Arevalo
Eduardo Castanon
Inés López
Josefa Salgado
Víctor Collado
Marta Santisteban
Maria E. Rodriguez-Ruiz
Patricia Martin
Leire Zubiri
Ana Patiño García
Christian Rolfo
Ignacio Gil Bazo

Background We studied whether thymidylate synthase (TS) genotype has an independent prognostic/predictive impact on a European population of advanced non-small cell lung cancer (NSCLC) patients receiving pemetrexed.

Keywords:

Thymidylate synthase
Pemetrexed
genomic DNA
Epidermal growth factor receptor
Cell
Genotype
Cancer research
Lung cancer
Medicine
Population
Diabetes mellitus
Polymerase chain reaction

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations